EUVIMEDEUVIMED entdecken
EditorialKommentar

Can optogenetics enlighten the way to treatment of obstructive sleep apnea?

David Gozal iD

SLEEP · 2023

DOI: 10.1093/sleep/zsad257 ↗

Kurz gefasst

Editorial in der Zeitschrift SLEEP, 2023. Verfasst von David Gozal. Beteiligte Einrichtung: Office of the Dean, Joan C. Edwards School of Medicine, Marshall University, Huntington, VA, USA. Hauptthemen laut MEDLINE: Optogenetics, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since its initial invention by Boyden and Deisseroth [1, 2], the use of optogenetics as a relatively minimally invasive tool for direct and precise in vivo induction of excitable cellular substrates including muscle contraction has gained tremendous popularity and has enabled major advances in our understanding of physiological traits including sleep [3, 4]. The major principle underlying optogenetic activation of such targeted cells involves the insertion of Channelrhodopsin-2 (ChR2) usually by using a viral vector. ChR2 is a light-sensitive microbial opsin that when expressed on cell membranes will act as a light-activated cation channel to induce membrane depolarization [5]. Using these approaches, spatial accuracy and temporal resolution following light-induced stimulation of transfected cells provide an extraordinarily sophisticated approach for delineation of physiological phenomena. Several groups of investigators have previously shown that optogenetic-mediated activation of skeletal muscle allows for precise and controlled contraction of specific muscle groups [6, 7]. In this issue of the Journal, Knapman et al. [8] explore the implementation of optogenetic strategies in an attempt to selectively activate upper airway dilator muscles. To this effect, the investigators performed a series of exploratory experiments that provided encouraging evidence whereby implementation of an AAV9 serotype along with a tCMK selective muscle cell promoter resulted in sufficient expression of the rhodopsin receptor to elicit muscle contractions upon light exposure in a rat model. The major objective of the study was to ascertain that under conditions of relative atonia of the upper airway musculature, photic stimulation would induce the activation of the tongue musculature. Such experiments were conducted in an acute anesthetized rat preparation using isoflurane as the anesthetic agent aiming to reduce in a dose-dependent fashion the atonia effect while not compromising the phasic diaphragmatic activity. The rationale for this model selection was that a phenotype manifesting reduced, yet reversible recruitment of dilator muscles was required such as to enable the application of photic stimulation to induce the desirable increases in phasic inspiratory dilator activity of the genioglossus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OptogeneticsSleep Apnea, ObstructiveHumansMuscle HypotoniaSleepMuscles

Autor:innen und Institutionen

  • Office of the Dean, Joan C. Edwards School of Medicine, Marshall University, Huntington, VA, USA.

ORCID-Profile: David Gozal

Zitieren

APA

Gozal, D. (2023). Can optogenetics enlighten the way to treatment of obstructive sleep apnea?. SLEEP. https://doi.org/10.1093/sleep/zsad257

Vancouver

Gozal D. Can optogenetics enlighten the way to treatment of obstructive sleep apnea?. SLEEP. 2023. doi:10.1093/sleep/zsad257

BibTeX
@article{Gozal2023,
  author = {Gozal, David},
  title = {Can optogenetics enlighten the way to treatment of obstructive sleep apnea?},
  journal = {SLEEP},
  year = {2023},
  doi = {10.1093/sleep/zsad257}
}
Kostenlos starten →